Clinical trial
Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients…
NCT00020839 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated
Key facts
| NCT number | NCT00020839 |
|---|---|
| Title | Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain |
| Official title | Temozolomide Versus Temozolomide + Whole Brain Radiation In Stage IV Melanoma Patients With Asymptomatic Brain Metastases |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Melanoma (Skin), Metastatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | temozolomide, radiation therapy |
| Enrollment | 23 |
| Start date | Apr 1, 2001 |
| Primary completion | May 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 24, 2012 |
| Countries | Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Norway, Portugal, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: